HIV AIDS

Eleven new drugs for HIV representing 5 new categories of mechanism of action are now in various phases of clinical trials. Here's an overview.

Here’s a case in point about progressive multifocal leukoencephalopathy in a patient with long-standing HIV who had never taken HART.

In new guidelines, the WHO and CDC stress that women should not be denied access to progestin-only injectables. The CDC recommendations for other hormonal contraceptive methods remain unchanged.

Patients coinfected with HIV and HCV who drink at least 3 cups of coffee a day can cut their risk of dying in half, says a new study.

An intelligent risk stratification algorithm can trigger a prompt for clinicians to offer an HIV test when they are ordering routine blood tests, potentially leading to earlier HIV diagnoses.

Empowerment interventions for women living with HIV can help decrease acquisition of other sexually transmitted infections.

Starting ART on the same day a patient tests positive for HIV may confer significant benefits. Details here.

A new report from The National Academy of Sciences outlines specific actions you can take now to help reduce hepatitis B and C infections.

Antiretroviral drug regimens have been implicated as factors in the increased risk of coronary artery disease and myocardial infarction in those with HIV infection. Here: practical measures for prevention and screening.

Slide Show: FDA drug approvals in the second quarter 2017 included these 10 for conditions seen in the primary care setting.